Immediate Impact
1 from Science/Nature 57 standout
Citing Papers
Visible Light-Induced Reactions of Diazo Compounds and Their Precursors
2024 Standout
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
2023 Standout
Works of Andrew Bryson being referenced
Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo‐controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)
2009
Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andrew Bryson | 362 | 128 | 133 | 11 | 647 | |
| Dana Troxclair | 171 | 83 | 96 | 17 | 696 | |
| P.R. Emmons | 279 | 39 | 104 | 10 | 616 | |
| Dianne E. Schwartz | 408 | 51 | 138 | 10 | 563 | |
| Annette Bak | 229 | 17 | 128 | 19 | 679 | |
| Henrik Mosén | 343 | 155 | 24 | 18 | 586 | |
| Christopher Doe | 218 | 17 | 113 | 21 | 572 | |
| D Antoniucci | 450 | 193 | 72 | 18 | 597 | |
| Edward K. Prokop | 274 | 86 | 111 | 27 | 712 | |
| Sergio Vancheri | 285 | 193 | 22 | 14 | 708 | |
| Arnd Christoph | 183 | 64 | 116 | 19 | 675 |
All Works
Loading papers...